About the Company
We do not have any company description for Alpha Tau Medical Ltd. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd: A Unique Player in Radiopharmaceuticals with ...
In a report released yesterday, Yigal Nochomovitz from Citi maintained a Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report), with a price target of $8.00.
Alpha Tau Medical Ltd.: Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
FDA approval of IDE to conduct a U.S. pilot study exploring the use of Alpha DaRT in patients with recurrent glioblastoma multiforme (GBM), a highly aggressive brain cancer - - Multiple U.S. clinical ...
Alpha Tau Medical Ltd. Reports Strong Financial Growth in H1 2025
Alpha Tau Medical Ltd ( ($DRTS) ) has provided an update. On August 11, 2025, Alpha Tau Medical Ltd. released its interim consolidated financial ...
Alpha Tau Medical Ltd. Appoints Maya Netser to Board of ... - Nasdaq
About Alpha Tau Medical Ltd. Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the ...
Buy Rating Justified for Alpha Tau Medical Ltd. on Back of Promising ...
Yi Chen, an analyst from H.C. Wainwright, reiterated the Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report). The associated price target remains the same with $9.00. Yi Chen has given ...
Alpha Tau Medical Ltd. Reports Promising Interim Results for ... - Nasdaq
Alpha Tau Medical Ltd. announced significant advancements in their alpha-radiation cancer treatment, Alpha DaRT®, during the 2025 ASCO GI Symposium and R&D Update Day.
Alpha Tau Medical Announces Second Quarter 2023 Financial Results and ...
Try Seeking Alpha for free by creating an account Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update Aug. 28, 2023 4:02 PM ET Alpha Tau Medical Ltd. (DRTS) ...
Alpha Tau Receives Medical Device Single Audit Program (MDSAP ...
JERUSALEM, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (DRTS) ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy ...
Could The Alpha Tau Medical Ltd. (NASDAQ:DRTS) Ownership ... - AOL
Alpha Tau Medical is not a large company by global standards. It has a market capitalization of US$663m, which means it wouldn't have the attention of many institutional investors.
Alpha Tau Medical to Participate in June Investor Conferences
Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it. About Alpha Tau Medical, Ltd.
Similar Companies
Loading the latest forecasts...